Technology
Clinical Trial Management System (CTMS) Market size is set to grow by USD 1.86 billion from 2024-2028, Increasing healthcare expenditure to boost the market growth, Technavio
Published
2 years agoon
By
NEW YORK, July 30, 2024 /PRNewswire/ — The global clinical trial management system (CTMS) market size is estimated to grow by USD 1.86 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 14.27% during the forecast period. Increasing healthcare expenditure is driving market growth, with a trend towards increasing outsourcing of clinical trial process. However, rising cost of clinical trials poses a challenge. Key market players include Advarra Inc., ArisGlobal LLC, Clinion Inc., Crucial Data Solutions Inc., Dassault Systemes SE, DATATRAK International Inc., DSG Inc., Ennov SAS, eResearchTechnology GmbH, International Business Machines Corp., Laboratory Corp. Of America Holdings, MasterControl Solutions Inc., Medfiles USA, MedNet, Oracle Corp., Parexel International Corp., PHARMASEAL, RealTime Software Solutions LLC, Veeva Systems Inc., and Wipro Ltd..
Get a detailed analysis on regions, market segments, customer landscape, and companies – Click for the snapshot of this report
Forecast period
2024-2028
Base Year
2023
Historic Data
2018 – 2022
Segment Covered
Deployment (On-premise and Cloud), End-user (Pharmaceutical and biotechnology companies, CROs, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW))
Region Covered
North America, Europe, Asia, and Rest of World (ROW)
Key companies profiled
Advarra Inc., ArisGlobal LLC, Clinion Inc., Crucial Data Solutions Inc., Dassault Systemes SE, DATATRAK International Inc., DSG Inc., Ennov SAS, eResearchTechnology GmbH, International Business Machines Corp., Laboratory Corp. Of America Holdings, MasterControl Solutions Inc., Medfiles USA, MedNet, Oracle Corp., Parexel International Corp., PHARMASEAL, RealTime Software Solutions LLC, Veeva Systems Inc., and Wipro Ltd.
Key Market Trends Fueling Growth
In the pharmaceutical industry, the shift towards outsourcing drug discovery processes to subcontract laboratories has been a significant trend since 2011. This transformation has enabled small companies to focus on manufacturing and marketing activities while outsourcing research and testing to external resources. The increasing popularity of this approach is due to the substantial cost savings it offers, as companies can outsource these functions for a fraction of the cost of building and maintaining their own research facilities. This outsourcing trend is particularly prevalent in countries like the US, the UK, Germany, and Japan, which have been outsourcing drug discovery to emerging economies such as India and Brazil. The high volume of data generated during the drug discovery process necessitates the use of Clinical Trial Management Systems (CTMS) to manage and analyze this data effectively. The growing number of tests carried out in subcontract laboratories has led to a corresponding increase in demand for CTMS solutions. CTMS plays a crucial role in streamlining the clinical trial process, ensuring compliance with regulatory requirements, and facilitating data management and analysis. As the outsourcing trend continues, the demand for CTMS is expected to grow, providing opportunities for market expansion.
The Clinical Trial Management System (CTMS) market is experiencing significant trends that are transforming the clinical trial landscape. Robust reporting and centralizing recruitment are key priorities for multinational companies and local CROs. ERegulatory, eSOURCE, accounting, and aggregate reporting provide network-wide visibility and oversight. Digitalization, personalized medicine, outsourcing, and externalization are driving growth in the market. Robust reporting, decentralized trial models, and evidence-based facilities are essential for regulatory compliance. ERegulatory, ERT, and Bioclinica are leading providers in Healthcare IT. Cloud-based CTMS, telemedicine solutions, and decentralized clinical trials are crucial in the current COVID-19 era. Costs, system security, backups, upgrades, and uptime consistency are critical considerations for CTM systems. AI and machine learning are enhancing trial efficiency and reducing costs. Vaccines and CTM systems are essential in the fight against COVID-19. The market is expected to continue growing, with investment in digitalization and regulatory policies being key drivers.
Discover 360° analysis of this market. For complete information, schedule your consultation- Book Here!
Market Challenges
Clinical trials are a crucial part of bringing new drugs to market, but their rising costs are a significant concern for the pharmaceutical industry. One major challenge is patient enrollment and retention, which can prolong the trial duration and increase expenses. According to various studies, the average cost per patient in the US for clinical trials is approximately USD41,117, with phase 3 trials being the most expensive, costing around USD20 million. Another factor contributing to the rising costs is the need for extensive clinical data collection due to new regulations. This can make trials complex and expensive, especially for drugs targeting chronic diseases. The longer a trial lasts, the more it costs, making clinical trial management systems essential to streamline the process. However, some clinical research associates may prefer manual work to cut costs, hindering the growth of the market. To address this issue, increasing patient awareness is the most feasible solution. By educating patients about the importance and benefits of clinical trials, the number of willing participants is likely to rise, reducing the overall cost and duration of trials. Pharmaceutical companies should focus on patient education rather than persuasion to ensure a successful clinical trial process.In the dynamic healthcare IT landscape, Clinical Trial Management Systems (CTMS) have become essential tools for managing complex clinical trials. However, implementing CTMS comes with challenges. Decentralized trials and the rise of vaccines require cloud-based CTMS for flexibility. Telemedicine solutions and COVID-NMA necessitate robust system security, backups, and upgrades. Centralization of data, growth, and AI/machine learning algorithms demand uptime consistency and automation. Clinical trial managers need access to data on devices like mobile workstations, laptops, and tablets via online dashboards. Trial planning, monitoring activities, regulatory procedures, supplies, finance, and subscription-based software upgrades require scalability. Add-ons, regulatory norms, document management processes, data quality, participant safety, and adherence to regulatory procedures are key considerations. Solutions like Clinion offer IWRS/RTSM, EDC, eCOA, accruals, deviations, and scalability to address these challenges.
For more insights on driver and challenges – Download a Sample Report
Segment Overview
This clinical trial management system (ctms) market report extensively covers market segmentation by
Deployment 1.1 On-premise1.2 CloudEnd-user 2.1 Pharmaceutical and biotechnology companies2.2 CROs2.3 OthersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)
1.1 On-premise- The Clinical Trial Management System (CTMS) market primarily consists of on-premises and cloud-based deployment models. On-premises CTMS offers enhanced data security and control, making it a preferred choice for large firms. However, the significant investment required for infrastructure and maintenance poses a challenge for smaller organizations. Conversely, cloud-based CTMS offers cost-effectiveness and ease of use. Major on-premises CTMS vendors include Siebel and IMPACT. Despite the high cost, large firms continue to prefer on-premises CTMS due to the perceived level of data security. This segment’s growth in the global CTMS market is anticipated to be driven by these factors during the forecast period.
For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2018 – 2022) – Download a Sample Report
Research Analysis
The Clinical Trial Management System (CTMS) market is a significant segment of Healthcare IT, facilitating the planning, execution, and management of clinical trials. With the increasing focus on decentralized clinical trials and the development of vaccines, CTMS solutions have gained prominence. Cloud-based CTMS is a popular choice due to its accessibility, scalability, and cost-effectiveness. Telemedicine solutions and IWRS/RTSM integrate seamlessly with CTMS, enhancing trial efficiency. EDC, eCOA, accruals, deviations, and robust reporting are essential features. Outsourcing and externalization to multinational companies and local CROs are common practices. Regulatory policies necessitate investment in CTMS solutions for ensuring compliance. Clario and other advanced systems offer features like ERT, making trial management more streamlined.
Market Research Overview
The Clinical Trial Management System (CTMS) market in Healthcare IT is experiencing significant growth due to the increasing adoption of decentralized clinical trials, particularly in the development of vaccines. Cloud-based CTMS solutions are gaining popularity for their accessibility and cost-effectiveness. Telemedicine solutions and AI-driven technologies, including machine learning algorithms and automation, are being integrated into CTMS to improve efficiency and data quality. Costs, system security, backups, and upgrades are key considerations for CTMS implementation. Uptime consistency, centralization of data, and regulatory norms are crucial for ensuring trial integrity and participant safety. Clinical trial managers require access to real-time data from devices such as mobile workstations, laptops, tablets, and online dashboards for effective trial planning, monitoring activities, and regulatory procedures. CTMS systems include modules for supplies, finance, and accounting on a subscription basis, with software upgrades and add-ons available for customization. Digitalization of clinical trials through eRegulatory, eSOURCE, IWRS/RTSM, EDC, eCOA, accruals, deviations, and scalable, robust reporting is driving growth in the market. Centralizing recruitment and network-wide visibility are also important for oversight and personalized medicine initiatives. Outsourcing and externalization to local CROs and multinational companies are common practices in the industry. Clario and other trial models are embracing decentralized approaches and evidence-based facilities to streamline regulatory policies and investment in the sector.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
DeploymentOn-premiseCloudEnd-userPharmaceutical And Biotechnology CompaniesCROsOthersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/clinical-trial-management-system-ctms-market-size-is-set-to-grow-by-usd-1-86-billion-from-2024-2028–increasing-healthcare-expenditure-to-boost-the-market-growth-technavio-302208770.html
SOURCE Technavio
You may like
Technology
Japan’s first DJI and Hasselblad Dual-Concept Flagship Store: “DJI | Hasselblad Authorized Concept Store Tokyo Omotesando” to Grand Open in Late October 2026!
Published
29 minutes agoon
October 22, 2026By
Offering an unprecedented creative experience with hands-on latest drones and medium-format cameras, an indoor drone flight cage, and 1-on-1 support from multilingual dedicated specialists
TOKYO, Oct. 22, 2026 /PRNewswire/ — DJI, the global leader in innovative aerial and imaging technology, will announce that SEKIDO Co., Ltd., an authorized domestic distributor, will hold the grand opening of the “DJI | Hasselblad Authorized Concept Store Tokyo Omotesando” in the Omotesando area of Tokyo on Saturday, October 31, 2026. This dual-concept store allows visitors to experience the combined worlds of DJI and Hasselblad, the Swedish premium camera brand boasting over 180 years of history as the pinnacle of medium-format photography.
The store consists of two floors, the first and second floors above ground, bringing together the world’s finest imaging technologies, from DJI’s latest drones, handheld gimbals, and action cameras to Hasselblad’s flagship medium-format digital camera systems. The store features a permanent indoor “Drone Flight Cage” for actual flight and operational experiences. It also offers 1-on-1 personalized consulting by expert staff and a multilingual support system (Japanese, English, and Chinese), strongly backing the expressive activities of all creators from Japan and abroad.
Background and Aim of Opening: A Permanent Flagship Hub to Meet the Growing Demand for “Real-World Experience and Expert Consultation”
The use of DJI products has been rapidly expanding in the Japanese market across a wide range of fields, including aerial photography, film and commercial production, still photography, and even industrial applications such as surveying and infrastructure inspection.
In recent years, while the demand for high-performance imaging equipment for creators has further increased, many customers have voiced their desire for real-world experiential value, stating, “I want to check the actual operational feel, image quality, and holding grip before purchasing,” and “I want to consult professionals to select the optimal equipment for my specific production needs and shooting environments.” For highly advanced equipment like drones in particular, it is extremely crucial to verify the intuitive operability and shooting sensation, which are difficult to convey solely through spec sheets and online information.
In response to these changing market dynamics, we decided to open a store in “Tokyo Omotesando,” an epicenter of trends and culture. This permanent flagship hub integrates “product experience,” “expert consulting,” and “experiencing the brand’s world view,” which cannot be fully covered by online sales and short-term events alone. We aim to create an open creative community space for all visual expressers, from highly sensitive top creators domestically and internationally to entry-level enthusiasts aspiring to begin serious content creation.
4 Key Highlights of “DJI Hasselblad Authorized Concept Store Tokyo Omotesando”
1. [Brand Convergence] A Dual-Concept Store to Experience the Worlds of DJI and Hasselblad
“DJI,” which develops innovative imaging technologies, and “Hasselblad,” which continues to support photographic expression as a historic medium-format camera brand. This is a new, dual-concept official store where the craftsmanship and cutting-edge technology of both brands intersect in a single space. From still images to motion pictures, and from the ground to the sky, we offer an equipment lineup that supports diverse creative activities.
2. [Real Experience] Indoor Drone Flight Cage & Product Touch & Try
On the 1st floor, a dedicated “Drone Flight Cage” is permanently installed, allowing visitors to safely fly and pilot drones. Without worrying about weather conditions or restricted flight areas, you can directly experience the hovering stability, camera operation, and control responsiveness of the latest drones on the spot. In addition, handheld cameras and gimbals such as the Osmo series led by the latest Osmo 360 II and Osmo Pocket 4P, as well as the Hasselblad medium-format cameras on the 2nd floor, are all displayed fully powered on, allowing you to freely pick them up and experience shooting.
3. [Expert Consultation] 1-on-1 Personalized Support System by Dedicated Specialists
Expert staff who are thoroughly familiar with product knowledge and on-site shooting know-how are permanently stationed at the store. We propose the optimal equipment configuration and peripheral accessories tailored to each customer’s shooting style, application, and business implementation goals. From comparing products to lectures on initial setup and consultation after introduction, we politely address all questions before and after purchase on a 1-on-1 basis.
4. [Global] Trilingual Support (Japanese, English, Chinese) to Fully Accommodate Inbound Demand
Tailored to the internationally diverse location of Omotesando, not only Japanese but also English and Chinese communication will be supported at the store. We have established a hospitable environment where international tourists and overseas business visitors can experience, purchase, and process tax exemptions for high-end equipment with peace of mind, without feeling any language barriers.
Floor Guide and Overview of Each Area
Each of the two floors offers independent themes and experiential value.
Floor
Main Exhibits and Services
1F
DJI Area
[DJI Touch & Try, Sales, and Flight Cage]
Latest aerial drones (Mavic series, Air series, Mini series, etc.)
Handheld gimbals and action cameras (Osmo Pocket, Osmo 360, Osmo Action, etc.)
Indoor drone flight cage (Actual piloting experience)
Product consultation by dedicated staff
2F
Hasselblad Area
[Hasselblad Touch & Try, Sales, and Gallery]
Medium-format mirrorless digital cameras (X2D II 100C, 907X series, etc.) and XCD lenses
Hasselblad art gallery (Exhibiting the overwhelming gradation and details captured by medium-format cameras)
Premium lounge and consulting booths for in-depth discussions in a relaxed atmosphere
Future Outlook: Regular Events and Workshops to Foster a Creator Community
This store will play a role not merely as an equipment sales hub, but as a communication hub where creators can connect, learn, and collaborate.
Following the grand opening, we plan to regularly host shooting workshops led by front-line professional photographers and video creators, drone flight experience seminars, and advance hands-on preview events for new products. Through the enthusiasm and learning opportunities unique to a physical store, we will contribute to the advancement of Japan’s creative culture.
Store Overview
Item
Store Basic Information
Store Name (Japanese)
DJI | Hasselblad Authorized Concept Store 東京表参道
Store Name (English)
DJI | Hasselblad Authorized Concept Store Tokyo Omotesando
Scheduled Opening Date & Time
Saturday, October 31, 2026 (Grand Opening)
Location
1F & 2F, La Porte Aoyama, 5-51-8 Jingumae, Shibuya-ku, Tokyo 150-0001
Access
4-minute walk from Exit B2 of Omotesando Station on the Tokyo Metro Ginza, Chiyoda,
and Hanzomon Lines
Business Hours / Holidays
11:00 – 20:00 (Planned) / Irregular holidays
Phone Number
03-6803-8400
Official Instagram
For details regarding the opening day and related campaigns, please check the store’s official Instagram or DJI’s official social media accounts.
We sincerely look forward to welcoming you to our store.
*Please note that all store images featured in this press release are computer-generated (CG) conceptual renderings. The actual design, layout, and specifications are subject to change without prior notice.
About DJI
Since its founding in 2006, DJI has pioneered the civilian drone industry, driving innovation while empowering individuals to take flight for the first time, turning imagination into reality, and continuously revolutionizing professional video production. Today, DJI strives every day with the goal of promoting human advancement and building a better world. With a solution-oriented mindset and genuine curiosity, DJI has expanded its business into fields such as renewable energy, agriculture, public safety, surveying and mapping, and infrastructure inspection. In each of these areas, DJI products create new value and bring unprecedented, fundamental changes to the lives of people around the world.
www.dji.com/jp | facebook.com/dji.jp | twitter.com/djijapan | youtube.com/DJIJapan | instagram.com/dji_japan | www.linkedin.com/company/dji
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/japans-first-dji-and-hasselblad-dual-concept-flagship-store-dji–hasselblad-authorized-concept-store-tokyo-omotesando-to-grand-open-in-late-october-2026-302916162.html
SOURCE DJI JAPAN
Technology
Shareholder Proposal Support Nudges Up as Proposal Volume Falls, Broadridge ProxyPulse™ Report Finds
Published
29 minutes agoon
October 22, 2026By
2026 proxy season sees a sharp decline in environmental and social proposals, a 10-year high in say-on-pay support and expanded opportunities for investor participation
NEW YORK, Oct. 22, 2026 /PRNewswire/ — Shareholder support for proposals increased in the 2026 proxy season even as the number of proposals continued to decline, according to the latest ProxyPulse™ report from global Fintech leader Broadridge (NYSE: BR). Average support for shareholder proposals rose to 27.9% from 24.3% in 2025 with increases in both retail and institutional investor segments.
“The number of environmental and social proposals that were voted on declined by 47% between the 2025 and 2026 proxy seasons,” said Chuck Callan, Senior Vice President of Regulatory Affairs at Broadridge. “At the same time, shareholder support for proposals on disclosing political spending, at 42% on average, rose to a new high. Backing for directors and say-on-pay remained strong, with say-on-pay support hitting a 10-year high.”
Retail Investors Vote More Shares as Participation Options Expand
Retail investors owned 6 billion more shares this season than last and voted 2 billion more of the shares they own. The report also highlights the continued expansion of “voting choice” and digital governance capabilities to expand the options that shareholders have to make their voices heard. More than 900 funds offered pass-through voting in the 12 months ended June 30, 2026, up from approximately 400 a year earlier, with more than 400,000 shareholders enrolled. Companies held a record 2,542 virtual shareholder meetings between July 2025 and June 2026, including more than 200 first-time adopters.
About ProxyPulse™
The 2026 Broadridge ProxyPulse report examines ownership and voting trends across the past five proxy seasons and explores developments shaping corporate governance, including standing voting instructions, voting choice and support for tokenized equities.
ProxyPulse™ is based on Broadridge’s processing of shares held in street name at the 1,000+ broker-dealers and custodian banks it services. Accounts are classified as either “retail” or “institutional” based on the delivery channels and voting platforms they utilize. All data is reported in the aggregate. Comparative information covers annual meetings between January 1 and June 30 in each of the past five years.
About Broadridge
Broadridge (NYSE: BR) is a global technology leader with trusted expertise and transformative technology, helping clients and the financial services industry operate, innovate, and grow. We power investing, governance, and communications for our clients – driving operational resiliency, elevating business performance, and transforming investor experiences.
Broadridge’s technology and operations platforms process and generate over 8 billion communications annually and underpin the daily average trading of over $18 trillion in tokenized and traditional securities globally. A certified Great Place to Work®, Broadridge is part of the S&P 500® Index, employing approximately 16,000 associates in 28 countries. For more information about us, please visit www.broadridge.com.
Broadridge Contacts:
Investors: broadridgeir@broadridge.com
Media: Gregg.Rosenberg@broadridge.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-proposal-support-nudges-up-as-proposal-volume-falls-broadridge-proxypulse-report-finds-302916293.html
SOURCE Broadridge Financial Solutions, Inc.
Technology
UMC and AP Memory Collaborate to Enable Advanced Power Delivery Solutions for AI and HPC Systems
Published
29 minutes agoon
October 22, 2026By
HSINCHU, Oct. 22, 2026 /PRNewswire/ — United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”) and AP Memory (TWSE: 6531) today announced a technology and manufacturing collaboration to advance power delivery solutions for AI and high-performance computing (HPC) systems. This partnership combines UMC’s deep trench capacitor (DTC) foundry technology and scalable wafer manufacturing with AP Memory’s silicon capacitor designs and system-level integration to address the power efficiency challenges of next-generation data centers.
Rapid scaling of AI workloads is placing unprecedented demands on power delivery within computing systems, driving an architecture shift in data center design from placing power stabilization components on the circuit board to embedding capacitors directly in the interposer or substrate. This innovative approach shortens the power delivery path, improves power integrity, and supports more efficient voltage regulation within advanced packages.
The collaboration reached a significant milestone in the third quarter of 2026, with AP Memory’s S-SiCap™ Gen2D discrete silicon capacitor designs completing tape-out and initial functional validation. The next step is to proceed to comprehensive system-level performance and reliability testing of capacitors in substrate packages, targeting support for a range of capacitance and operating voltage requirements. UMC and AP Memory are also exploring opportunities to extend the collaboration to other product lines including capacitor-embedded interposers and landside capacitors to address diverse system designs.
GC Hung, Senior Vice President of UMC, said: “The growth of AI and HPC is driving a fundamental shift in power delivery – from board-level towards increasingly vertical power integration on the chip-level. UMC is offering robust power delivery solutions, including our DTC technology, which enables high-density capacitance to be placed closer to the computing die for more stable power delivery. By partnering with AP Memory, we are helping to bring scalable solutions to the market to solve the critical power bottleneck challenges as AI infrastructure continues to evolve.”
Ivan Hong, President of AP Memory, said: “The successful tape-out and initial wafer validation of our customized S-SiCap™ products using DTC technology represents an important milestone in demonstrating the flexibility and manufacturability of AP Memory’s S-SiCap™ design. By working with UMC, we are providing our customers a total solution, from product design to wafer manufacturing.”
UMC’s power delivery solutions roadmap covers both discrete and embedded silicon capacitors that can be applied to different system architectures, and extends to active components such as internal voltage regulators. UMC is also leveraging its advanced packaging capabilities to enable higher-density integration of power components to meet the higher voltage and capacitance requirements of next-generation data centers. In parallel, UMC is further investing in new manufacturing capacity to support both power delivery and heterogeneous integration solutions.
About UMC
UMC (NYSE: UMC, TWSE: 2303) is a leading global semiconductor foundry company. The company provides high-quality IC fabrication services, focusing on logic and various specialty technologies to serve all major sectors of the electronics industry. UMC’s comprehensive IC processing technologies and manufacturing solutions include Logic/Mixed-Signal, embedded High-Voltage, embedded Non-Volatile-Memory, RFSOI, BCD etc. Most of UMC’s 12-in and 8-in fabs with its core R&D are located in Taiwan, with additional ones throughout Asia. UMC has a total of 12 fabs in production with combined capacity of more than 400,000 wafers per month (12-in equivalent), and all of them are certified with IATF 16949 automotive quality standard. UMC is headquartered in Hsinchu, Taiwan, plus local offices in United States, Europe, China, Japan, Korea & Singapore, with a worldwide total of 20,000 employees. For more information, please visit: http://www.umc.com.
Note from UMC Concerning Forward-Looking Statements
Some of the statements in the foregoing announcement are forward-looking within the meaning of the U.S. Federal Securities laws, including statements about introduction of new services and technologies, future outsourcing, competition, wafer capacity, business relationships and market conditions. Investors are cautioned that actual events and results could differ materially from these statements as a result of a variety of factors, including conditions in the overall semiconductor market and economy; acceptance and demand for products from UMC; and technological and development risks. Further information regarding these and other risks is included in UMC’s filings with the U.S. Securities and Exchange Commission. UMC does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.
About AP Memory
AP Memory (TWSE: 6531) is a global fabless design semiconductor company specializing in customized memory design and IP solutions. Products include IoT memory (IoTRAM™), AI memory solutions (VHM™), and silicon capacitors (S-SiCap™). With strong R&D capabilities, AP Memory is committed to providing high performance, low-power and innovative customized products and solutions for applications such as mobile communication, wearable, IoT, high-end mobile application, high-performance computing, and edge computing.
View original content to download multimedia:https://www.prnewswire.com/news-releases/umc-and-ap-memory-collaborate-to-enable-advanced-power-delivery-solutions-for-ai-and-hpc-systems-302916408.html
SOURCE United Microelectronics Corporation; AP Memory Technology Corp.
Japan’s first DJI and Hasselblad Dual-Concept Flagship Store: “DJI | Hasselblad Authorized Concept Store Tokyo Omotesando” to Grand Open in Late October 2026!
Shareholder Proposal Support Nudges Up as Proposal Volume Falls, Broadridge ProxyPulse™ Report Finds
UMC and AP Memory Collaborate to Enable Advanced Power Delivery Solutions for AI and HPC Systems
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Near Videos5 days agoWhat if you could build a skyscraper with one prompt?
-
Technology5 days agoHighland and Bath Counties, Virginia Go Live on a Shared Caliber Hosted CAD Environment
-
Technology5 days agoJinkoSolar Unveils Tiger Neo 5.0 All-Black Residential Solar Module with 25.52% Efficiency
-
Technology4 days agoBioethanol from human hair – Indian start-up’s solution to rising prices of grains and sugar
-
Technology3 days agoGMIF2026: AI Inference Powers the “Token Factory” and Drives System-Level Rethinking of Memory & Storage
-
Technology4 days agoLinktel Technologies Highlights Breakthrough 1.6T LPO Performance & Strong Market Pull at OCP 2026
-
Technology3 days agoInstaMall Launches Same-Day Fashion Delivery Experience, Bringing 80+ Brands to Shoppers’ Doors in Miami
-
Technology3 days agoTruecaller announces preliminary numbers for the third quarter 2026
